Charts Purple Biotech Ltd

Equities

Delayed TEL AVIV STOCK EXCHANGE Other stock markets 03:22:12 2024-05-19 am EDT			5-day change	1st Jan Change
20.1 ^ILa	+12.92%		+3.61%	-36.99%

Apr. 25	Purple Biotech Ltd.'s Randomized Phase 2 CM24 Pancreatic Cancer Study Selected as Late-Breaking Abstract Poster Presentation at ASCO 2024 Annual Meeting	CI
Mar. 14	Purple Biotech Reports Preclinical Proof of Concept for Its Tribody Platform Technology	CI

ProRealTime Chart